Maximizing crowd engagement on male/female differences in Alzheimer’s disease

Last week I was privileged to represent InnoCentive at the Alzheimer’s Disease Summit: The Path to 2025 at the New York Academy of Sciences, supporting the final stage of the 2013 Geoffrey Beene Global NeuroDiscovery Challenge.

Made possible by the collaboration of Geoffrey Beene Foundation Alzheimer’s Initiative (GBFAI), Foundation for the National Institutes of Health, Institute of Medicine, Women Against Alzheimer’s Network, 21st Century BrainTrust™, BrightFocus Foundation, Brigham & Women’s Hospital, Boston, Mass Bio, and Society for Women’s Health Research; and powered by InnoCentive, this challenge asked Solvers to identify male/female differences and the impact on neurodegenerative progression leading to Alzheimer’s disease.

Read full article.